{"id":587,"date":"2016-03-14T09:23:54","date_gmt":"2016-03-14T17:23:54","guid":{"rendered":"http:\/\/microcapspot.com\/?p=587"},"modified":"2016-03-14T09:23:54","modified_gmt":"2016-03-14T17:23:54","slug":"exciting-developments-pharmacyte-biotech-inc-otcmktspmcb","status":"publish","type":"post","link":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/","title":{"rendered":"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB)"},"content":{"rendered":"<p>Pharmacyte Biotech Inc (OTCMKTS:PMCB) is skyrocketing on its new anticipated treatment for pancreatic cancer. The stock surged forward with gains locking in at 6.40% and the stock advancing over 50% since the beginning of the year. Over 1 million shares were traded on Friday and the stock continues to be heavily traded on a daily basis.<\/p>\n<p>PMCB just released its financial information with the SEC according to a recent filing. PMCB is set to launch a new clinical trial sometime in 2016 for pancreatic cancer patients. There is a huge unmet medical need and people will welcome a solution that could potentially increase the lifespan for late stage pancreatic patients. If the clinical trial is successful, PMCB will be gaining more than just 50% to investors and likely cause the company to increase in value significantly and potentially be acquired by a larger pharmaceutical company.<\/p>\n<p>Any positive results would move PMCB into the spotlight and above other early stage biotechs who are trying to come up with a solution as well. There would be a substantial increase in the company\u2019s value and it would absolutely be able to attract major attention from large pharmaceutical companies. It would give a much needed viable option for pancreatic cancer treatment.<\/p>\n<p>The market size for pancreatic cancer is huge. Looking only at major developed countries, the market size should reach close to $3 billion within the next 5 years. If we look at the addressable market that in the United States only is equally impressive, which PMCB should easily be able to attain. A typical drug price for this disease is roughly between $50k and $75k per year. There are about 43,000 patients diagnosed with pancreatic cancer a year. Assuming that 60% of the patient pool would switch to PMCBs drug, the market size in the USA could be estimated at $1.25 billion to $1.8 billion. Given the market valuation is only $51 million, a successful positive trail will send shares flying through the stratosphere.<\/p>\n<p style=\"text-align: center;\"><span style=\"color: #ff0000;\"><strong>We have a Monster Pick Coming. Subscribe Right Now!<\/strong><\/span><br \/>\n<span style=\"color: #ff0000;\"><strong> [newsletter_form]<\/strong><\/span><\/p>\n<p style=\"text-align: center;\"><img loading=\"lazy\" class=\"aligncenter size-full wp-image-589\" src=\"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/sc-1-16.png\" alt=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\" width=\"700\" height=\"312\" srcset=\"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/sc-1-16.png 700w, https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/sc-1-16-300x134.png 300w\" sizes=\"(max-width: 700px) 100vw, 700px\" \/><\/p>\n<p>PMCB is currently trading at a $51 million market valuation. PMCB is developing a revolutionary therapy that could provide relief to thousands of patients every year that are diagnosed. There is a huge market that PMCB will be able to successfully operate in if clinical trials yield positive results. Even though a fully FDA approved drug is likely a long way out, advances and positive news will send shares flying. Stay tuned for more updates.<\/p>\n<p style=\"text-align: center;\"><span style=\"color: #ff0000;\"><strong>We will be updating on PMCB when more details emerge so make sure you are subscribed to Microcapspot so you know what\u2019s going on with PMCB .<\/strong><\/span><\/p>\n<p>Disclosure: we hold no position in PMCB either long or short and we have not been compensated for this article.    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacyte Biotech Inc (OTCMKTS:PMCB) is skyrocketing on its new anticipated treatment for pancreatic cancer. The stock surged forward with gains locking in at 6.40% and the stock advancing over 50% since the beginning of the year. Over 1 million shares were traded on Friday and the stock continues to be heavily traded on a daily [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":588,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.4.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB) - MicroCap Spot<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB) - MicroCap Spot\" \/>\n<meta property=\"og:description\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) is skyrocketing on its new anticipated treatment for pancreatic cancer. The stock surged forward with gains locking in at 6.40% and the stock advancing over 50% since the beginning of the year. Over 1 million shares were traded on Friday and the stock continues to be heavily traded on a daily [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/\" \/>\n<meta property=\"og:site_name\" content=\"MicroCap Spot\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-14T17:23:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RJohnson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/microcapspot.com\/#organization\",\"name\":\"MicroCap Spot\",\"url\":\"https:\/\/microcapspot.com\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/microcapspot.com\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/microcapspot.com\/wp-content\/uploads\/2020\/04\/MicroCap-Spotlight-OTC-Stock-Market-News.png\",\"contentUrl\":\"https:\/\/microcapspot.com\/wp-content\/uploads\/2020\/04\/MicroCap-Spotlight-OTC-Stock-Market-News.png\",\"width\":382,\"height\":78,\"caption\":\"MicroCap Spot\"},\"image\":{\"@id\":\"https:\/\/microcapspot.com\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/microcapspot.com\/#website\",\"url\":\"https:\/\/microcapspot.com\/\",\"name\":\"MicroCap Spot\",\"description\":\"News, Research &amp; Analysis\",\"publisher\":{\"@id\":\"https:\/\/microcapspot.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/microcapspot.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg\",\"contentUrl\":\"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#webpage\",\"url\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/\",\"name\":\"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB) - MicroCap Spot\",\"isPartOf\":{\"@id\":\"https:\/\/microcapspot.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#primaryimage\"},\"datePublished\":\"2016-03-14T17:23:54+00:00\",\"dateModified\":\"2016-03-14T17:23:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/microcapspot.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB)\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#webpage\"},\"author\":{\"@id\":\"https:\/\/microcapspot.com\/#\/schema\/person\/79c1de6bfee712691158ea3e3b6bff78\"},\"headline\":\"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB)\",\"datePublished\":\"2016-03-14T17:23:54+00:00\",\"dateModified\":\"2016-03-14T17:23:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#webpage\"},\"wordCount\":461,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/microcapspot.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg\",\"articleSection\":[\"Energy &amp; Materials\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/microcapspot.com\/#\/schema\/person\/79c1de6bfee712691158ea3e3b6bff78\",\"name\":\"RJohnson\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/microcapspot.com\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g\",\"caption\":\"RJohnson\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB) - MicroCap Spot","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/","og_locale":"en_US","og_type":"article","og_title":"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB) - MicroCap Spot","og_description":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) is skyrocketing on its new anticipated treatment for pancreatic cancer. The stock surged forward with gains locking in at 6.40% and the stock advancing over 50% since the beginning of the year. Over 1 million shares were traded on Friday and the stock continues to be heavily traded on a daily [&hellip;]","og_url":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/","og_site_name":"MicroCap Spot","article_published_time":"2016-03-14T17:23:54+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"RJohnson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/microcapspot.com\/#organization","name":"MicroCap Spot","url":"https:\/\/microcapspot.com\/","sameAs":[],"logo":{"@type":"ImageObject","@id":"https:\/\/microcapspot.com\/#logo","inLanguage":"en-US","url":"https:\/\/microcapspot.com\/wp-content\/uploads\/2020\/04\/MicroCap-Spotlight-OTC-Stock-Market-News.png","contentUrl":"https:\/\/microcapspot.com\/wp-content\/uploads\/2020\/04\/MicroCap-Spotlight-OTC-Stock-Market-News.png","width":382,"height":78,"caption":"MicroCap Spot"},"image":{"@id":"https:\/\/microcapspot.com\/#logo"}},{"@type":"WebSite","@id":"https:\/\/microcapspot.com\/#website","url":"https:\/\/microcapspot.com\/","name":"MicroCap Spot","description":"News, Research &amp; Analysis","publisher":{"@id":"https:\/\/microcapspot.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microcapspot.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#primaryimage","inLanguage":"en-US","url":"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg","contentUrl":"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg","width":1024,"height":768},{"@type":"WebPage","@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#webpage","url":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/","name":"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB) - MicroCap Spot","isPartOf":{"@id":"https:\/\/microcapspot.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#primaryimage"},"datePublished":"2016-03-14T17:23:54+00:00","dateModified":"2016-03-14T17:23:54+00:00","breadcrumb":{"@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microcapspot.com\/"},{"@type":"ListItem","position":2,"name":"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB)"}]},{"@type":"Article","@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#article","isPartOf":{"@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#webpage"},"author":{"@id":"https:\/\/microcapspot.com\/#\/schema\/person\/79c1de6bfee712691158ea3e3b6bff78"},"headline":"Exciting Developments at Pharmacyte Biotech Inc (OTCMKTS:PMCB)","datePublished":"2016-03-14T17:23:54+00:00","dateModified":"2016-03-14T17:23:54+00:00","mainEntityOfPage":{"@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#webpage"},"wordCount":461,"commentCount":0,"publisher":{"@id":"https:\/\/microcapspot.com\/#organization"},"image":{"@id":"https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#primaryimage"},"thumbnailUrl":"https:\/\/microcapspot.com\/wp-content\/uploads\/2016\/03\/biotech-6-1024x768-1.jpg","articleSection":["Energy &amp; Materials"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microcapspot.com\/exciting-developments-pharmacyte-biotech-inc-otcmktspmcb\/#respond"]}]},{"@type":"Person","@id":"https:\/\/microcapspot.com\/#\/schema\/person\/79c1de6bfee712691158ea3e3b6bff78","name":"RJohnson","image":{"@type":"ImageObject","@id":"https:\/\/microcapspot.com\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"RJohnson"}}]}},"_links":{"self":[{"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/posts\/587"}],"collection":[{"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/comments?post=587"}],"version-history":[{"count":0,"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/posts\/587\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/media\/588"}],"wp:attachment":[{"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/media?parent=587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/categories?post=587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microcapspot.com\/wp-json\/wp\/v2\/tags?post=587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}